Anzeige
Mehr »
Samstag, 07.06.2025 - Börsentäglich über 12.000 News
Starke Zahlen: EBITDA bei 9 Mio.?€ - Startet jetzt die Neubewertung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A110VV | ISIN: SE0005794617 | Ticker-Symbol: 30S
Frankfurt
06.06.25 | 09:57
0,909 Euro
+8,73 % +0,073
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
SANIONA AB Chart 1 Jahr
5-Tage-Chart
SANIONA AB 5-Tage-Chart
RealtimeGeldBriefZeit
0,8140,89906.06.

Aktuelle News zur SANIONA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
28.05.Saniona AB: Bulletin from the Saniona AB annual shareholders' meeting on May 28, 202587Today, on May 28, 2025, the annual shareholders' meeting was held in Saniona AB. A summary of the adopted resolutions follows below. Resolution on adoption of accounts and distribution of the company's...
► Artikel lesen
12.05.Saniona AB: Saniona appoints Johnny Stilou as Chief Financial Officer121Saniona (OMX: SANION), a clinical-stage biopharmaceutical company, today announces the appointment of Johnny Stilou as Chief Financial Officer, effective immediately. He brings more than 25 years of...
► Artikel lesen
10.04.Saniona - Broad pipeline to address neurological conditions302Saniona is a European pioneer in ion channel drug discovery. Internally, it is primarily focused on its preclinical epilepsy pipeline: SAN2355 (for focal/generalised epilepsy) and SAN2219 (for acute...
► Artikel lesen
28.03.Saniona's CSO to "We are on track with SAN2219"2
26.03.Saniona's CEO to "The TO4 proceeds give us flexibility to secure the best deals"2
SANIONA Aktie jetzt für 0€ handeln
26.03.Saniona AB: Saniona initiates scale-up and manufacturing of toxicology batches for SAN2219, a potential new therapy for epilepsy187Saniona (OMX: SANION), a clinical-stage biopharmaceutical company, today announces the initiation of scale-up and manufacturing of toxicology batches for SAN2219, advancing the program toward clinical...
► Artikel lesen
12.03.Saniona's new CMO to "More deals are definitely on the horizon"2
11.03.Saniona AB: Saniona and Boehringer Ingelheim extend research collaboration with one year479Saniona (OMX: SANION), a clinical stage biopharmaceutical company, today announced that the ongoing ion channel research collaboration with Boehringer Ingelheim has been extended with one year. "The...
► Artikel lesen
10.03.Saniona AB: Saniona Appoints Pierandrea Muglia, M.D., as Chief Medical Officer113Saniona (OMX: SANION), a clinical-stage biopharmaceutical company, today announces the appointment of Pierandrea Muglia, M.D., as Chief Medical Officer. Dr. Muglia brings more than 30 years of experience...
► Artikel lesen
07.03.Saniona's CEO comments on the recent news2
03.03.Acadia Pharmaceuticals Inc.: Acadia Pharmaceuticals and Saniona Announce Initial Positive Results from ACP-711 (formerly SAN711) Phase 1 Study346Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) and Saniona (OMX: SANION) today announced the successful completion of the two originally planned cohorts in their Phase 1 multiple-ascending-dose MAD study...
► Artikel lesen
28.02.Saniona strengthened its cash position and advanced through partnership4
27.02.Saniona AB: Saniona publishes its year-end report for 2024118Three Months Ended December 31, 2024 (2023)Twelve Months Ended December 31, 2024 (2023)Revenue was SEK 313.4 M (5.4 M)Revenue was SEK 334.7 M (16.8 M)Operating profit/loss was SEK 290.4 M (-19.8 M)Operating...
► Artikel lesen
24.02.Saniona's CEO responds to investors' questions2
11.02.BIOSTOCK: Watch the interview with Saniona1
10.02.BIOSTOCK: Live interview with Saniona tomorrow - submit your questions!1
16.01.Saniona-backed Cephagenix secures 9 MEUR in seed financing1
28.11.24Saniona AB: Saniona publishes its interim report for the third quarter of 2024190Three Months Ended September 30, 2024 (2023)Nine Months Ended September 30, 2024 (2023)Revenue was SEK 7.2 M (5.5 M)Revenue was SEK 21.3 M (11.5 M)Operating profit/loss was SEK -18.9 M (-18.4 M)Operating...
► Artikel lesen
14.10.24Saniona AB: Saniona Ion Channel Research Collaboration with Boehringer Ingelheim Reaches Milestone497Saniona (OMX: SANION), a clinical-stage biopharmaceutical company, today announces that its ongoing ion channel research collaboration with Boehringer Ingelheim has advanced to the lead optimization...
► Artikel lesen
29.08.24Saniona AB: Saniona publishes its interim report for the second quarter of 2024147Three Months Ended June 30, 2024 (2023)Six Months Ended June 30, 2024 (2023)Revenue was SEK 8.0 M (3.9 M)Revenue was SEK 14.1 M (6.0 M)Operating profit/loss was SEK -16.0 M (-21.8 M)Operating profit/loss...
► Artikel lesen
Weiter >>
21 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1